Biosound signs deal with Summit
Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced
Ultrasound developer Biosound Esaote reported last month that it has brokered a partnership with Summit Medical Technologies of Arlington Heights, IL. The deal gives Summit exclusive U.S. marketing rights to Indianapolis-based Biosound's Advanced Ultrasonography (AU) line of scanners. Summit will sell the units to radiologists, medical imaging centers, and breast imaging centers, while Biosound's sales force will continue to sell the system to remaining markets, including cardiology, vascular and general surgery, and neurology.
The most recent system in the AU family is AU5, introduced last year and cleared by the Food and Drug Administration this September (SCAN 9/17/97). Biosound hopes the deal with Summit Medical will give it increased access to the multispecialty radiology market and the women's health market.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
